SARS‐CoV‐2 Omicron variants in Bangladesh: Pandemic to endemic

SARS‐CoV‐2 Omicron variants in Bangladesh: Pandemic to endemic

Bibliographic Details
Main Authors:	Mohammad Jubair, Mst. Noorjahan Begum, Sezanur Rahman, Sourav Mohammad Arefeen Haider, Shovan B. Moon, Mohammad Enayet Hossain, Mohammed Ziaur Rahman, Manjur H. Khan, Ahmed N. Alam, Tahmina Shirin, Mokibul H. Afrad, Firdausi Qadri, Mustafizur Rahman
Format:	Article
Language:	English
Published:	Wiley 2023-03-01
Series:	Health Science Reports
Subjects:	COVID‐19 Omicron protection reinfection SARS‐CoV‐2 XBB
Online Access:	https://doi.org/10.1002/hsr2.1134

Similar Items

Natural selection shapes the evolution of SARS-CoV-2 Omicron in Bangladesh
by: Mohammad Tanbir Habib, et al.
Published: (2023-08-01)

Dynamic changes of neutralizing antibody and memory T cell responses six months post Omicron XBB reinfection
by: Xin-Jing Zhao, et al.
Published: (2024-10-01)

Does the COVID-19 XBB Omicron subvariant signal the beginning of the end of the pandemic?
by: Jinghao Nicholas Ngiam, et al.
Published: (2024-12-01)

The rapid rise of SARS‐CoV‐2 Omicron subvariants with immune evasion properties: XBB.1.5 and BQ.1.1 subvariants
by: Danyi Ao, et al.
Published: (2023-04-01)

The emergence of the Omicron XBB.1.5 variant in India: a brief report on clinical presentation of a few cases
by: Jasmine Samal, et al.
Published: (2023-06-01)

The Omicron XBB.1 Variant and Its Descendants: Genomic Mutations, Rapid Dissemination and Notable Characteristics
by: Raffaele Giancotti, et al.
Published: (2024-02-01)

Tracking SARS-CoV-2 variants during the 2023 flu season and beyond in Lebanon
by: Ibrahim Al Kodsi, et al.
Published: (2024-01-01)

Predictors of reinfection with pre-Omicron and Omicron variants of concern among individuals who recovered from COVID-19 in the first year of the pandemic
by: Dani Cohen, et al.
Published: (2023-07-01)

Characteristics of Omicron variant-induced SARS-CoV-2 reinfections in Chengdu, China
by: Yingxue DAI, et al.
Published: (2023-04-01)

The Omicron Variant Reinfection Risk among Individuals with a Previous SARS-CoV-2 Infection within One Year in Shanghai, China: A Cross-Sectional Study
by: Chuchu Ye, et al.
Published: (2023-06-01)

Comprehensive Analysis of SARS-CoV-2 Dynamics in Bangladesh: Infection Trends and Variants (2020–2023)
by: Mst. Noorjahan Begum, et al.
Published: (2024-08-01)

Healthcare-Associated SARS-CoV-2 Reinfection after 3 Months with a Phylogenetically Distinct Omicron Variant: A Case Report
by: Kim Callebaut, et al.
Published: (2022-08-01)

Asthma control after recovery from mild to moderate COVID-19: from Omicron BA.2 to XBB– from a cohort in a university hospital in Hong Kong
by: Wang Chun Kwok, et al.
Published: (2025-02-01)

Differentiating Cell Entry Potentials of SARS-CoV-2 Omicron Subvariants on Human Lung Epithelium Cells
by: Revansiddha H. Katte, et al.
Published: (2024-03-01)

Omicron variants of SARS-CoV-2: Epidemiological and clinical insights from a tertiary care center in Saudi Arabia
by: Bayan Dubaie, et al.
Published: (2024-06-01)

Comparison of immune responses to SARS-CoV-2 spike following Omicron infection or Omicron BA.4/5 vaccination in kidney transplant recipients
by: Inga Tometten, et al.
Published: (2025-01-01)

An omicron-specific neutralizing antibody test predicts neutralizing activity against XBB 1.5
by: Stephen Varvel, et al.
Published: (2024-01-01)

Serial infection with SARS-CoV-2 Omicron BA.1 and BA.2 following three-dose COVID-19 vaccination
by: Hope R. Lapointe, et al.
Published: (2022-09-01)

Next generation sequencing of multiple SARS-CoV-2 infections in the Omicron Era
by: Marzia Cavalli, et al.
Published: (2025-01-01)

Immediate reinfection with Omicron variant after clearance of a previous SARS-CoV-2 infection
by: Antonella Mencacci, et al.
Published: (2022-09-01)

Long-Term Immunity against SARS-CoV-2 Wild-Type and Omicron XBB.1.5 in Indonesian Residents after Vaccination and Infection
by: Karismananda, et al.
Published: (2024-09-01)

Immune Evasion of SARS-CoV-2 Omicron Subvariants XBB.1.5, XBB.1.16 and EG.5.1 in a Cohort of Older Adults after ChAdOx1-S Vaccination and BA.4/5 Bivalent Booster
by: Rafael Rahal Guaragna Machado, et al.
Published: (2024-01-01)

COVID-19 Vaccine Booster Dose Fails to Enhance Antibody Response to Omicron Variant in Reinfected Healthcare Workers
by: Leire Fernández-Ciriza, et al.
Published: (2025-01-01)

SARS-CoV-2 Omicron Symptomatic Infections in Previously Infected or Vaccinated South African Healthcare Workers
by: Marta C. Nunes, et al.
Published: (2022-03-01)

XBB.1.16 Omicron subvariant rise to a variant of interest: Implications for global alertness and preparedness
by: Okesanya Olalekan John, B'MLS, et al.
Published: (2023-12-01)

The antiviral activity of a small molecule drug targeting the NSP1-ribosome complex against Omicron, especially in elderly patients
by: Min Shen, et al.
Published: (2023-03-01)

Incidence of SARS-CoV-2 Infection during the Omicron Variant Emergence in Southern Vietnam: Prior Infection versus Third-Dose Vaccination
by: Thang Thanh Phan, et al.
Published: (2022-10-01)

Waning natural and vaccine-induced immunity leading to reinfection with SARS-CoV-2 Omicron variant
by: Anita M. Shete, et al.
Published: (2022-11-01)

Conceptualization of Covid-19 in New Life Post Covid-19 Pandemic: A Semantic Cognitive Appoach
by: Deanty Rumandang Bulan, et al.
Published: (2023-05-01)

A Case Series Describing the Recurrence of COVID-19 in Patients Who Recovered from Initial Illness in Bangladesh
by: Pritimoy Das, et al.
Published: (2021-03-01)

A mini review of reinfection with the SARS‐CoV‐2 Omicron variant
by: Hongwei Shen, et al.
Published: (2024-04-01)

XBB.1.5: A new threatening SARS-CoV-2 Omicron subvariant
by: Md. Aminul Islam, et al.
Published: (2023-04-01)

Significant rise in SARS-CoV-2 reinfection rate in vaccinated Hospital workers during the omicron wave: A prospective cohort study
by: Eric Ochoa-Hein, et al.
Published: (2022-10-01)

An updated review of epidemiological characteristics, immune escape, and therapeutic advances of SARS-CoV-2 Omicron XBB.1.5 and other mutants
by: Zongming Liu, et al.
Published: (2023-12-01)

Assessment of neutralization susceptibility of Omicron subvariants XBB.1.5 and BQ.1.1 against broad-spectrum neutralizing antibodies through epitopes mapping
by: Masaud Shah, et al.
Published: (2023-09-01)

Divergent pathogenetic outcomes in BALB/c mice following Omicron subvariant infection
by: John M. Powers, et al.
Published: (2024-03-01)

The serological IgG and neutralizing antibody of SARS-CoV-2 omicron variant reinfection in Jiangsu Province, China
by: Jinjin Chu, et al.
Published: (2024-05-01)

Validation of a Pseudovirus Neutralization Assay for Severe Acute Respiratory Syndrome Coronavirus 2: A High-Throughput Method for the Evaluation of Vaccine Immunogenicity
by: Zhaohui Cai, et al.
Published: (2024-06-01)

SARS-CoV-2 omicron BA.5 and XBB variants have increased neurotropic potential over BA.1 in K18-hACE2 mice and human brain organoids
by: Romal Stewart, et al.
Published: (2023-11-01)

Genomic Surveillance Reveals the Rapid Expansion of the XBB Lineage among Circulating SARS-CoV-2 Omicron Lineages in Southeastern Wisconsin, USA
by: Arunachalam Ramaiah, et al.
Published: (2023-09-01)